Tags

Type your tag names separated by a space and hit enter

Current treatments for scabies and pediculosis.
Skin Therapy Lett. 1999; 5(1):1-3.ST

Abstract

Scabies and lice have afflicted man since ancient times. Permethrin is generally the treatment of choice for head lice and scabies, because of its residual effect. Toxicity and absorption are minimal. Ivermectin should be reserved for cases where permethrin fails.

Authors+Show Affiliations

The George Washington School of Medicine, Washington, DC, USA.

Pub Type(s)

Journal Article

Language

eng

PubMed ID

10751840

Citation

Elgart, M L.. "Current Treatments for Scabies and Pediculosis." Skin Therapy Letter, vol. 5, no. 1, 1999, pp. 1-3.
Elgart ML. Current treatments for scabies and pediculosis. Skin Therapy Lett. 1999;5(1):1-3.
Elgart, M. L. (1999). Current treatments for scabies and pediculosis. Skin Therapy Letter, 5(1), 1-3.
Elgart ML. Current Treatments for Scabies and Pediculosis. Skin Therapy Lett. 1999;5(1):1-3. PubMed PMID: 10751840.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Current treatments for scabies and pediculosis. A1 - Elgart,M L, PY - 2000/4/7/pubmed PY - 2000/10/7/medline PY - 2000/4/7/entrez SP - 1 EP - 3 JF - Skin therapy letter JO - Skin Therapy Lett VL - 5 IS - 1 N2 - Scabies and lice have afflicted man since ancient times. Permethrin is generally the treatment of choice for head lice and scabies, because of its residual effect. Toxicity and absorption are minimal. Ivermectin should be reserved for cases where permethrin fails. SN - 1201-5989 UR - https://brain.unboundmedicine.com/medline/citation/10751840/Current_treatments_for_scabies_and_pediculosis_ L2 - https://medlineplus.gov/scabies.html DB - PRIME DP - Unbound Medicine ER -